Seelos Therapeutics (SEELQ) Live Share Price, Invest From India

Seelos Therapeutics Stock Performance

as on October 23, 2026 at 5:02 am IST

Day's Price Range
52-Week Price Range

Seelos Therapeutics share price movements today

Previous Close: -
Open: -
Volume: 223.0
Market Cap: $5.0

Seelos Therapeutics Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: -99 %
3 Year Return: 0 %
5 Year Return: 0 %

Seelos Therapeutics Stock Fundamentals & Key Indicators

Check Seelos Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.0

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

Return On Equity TTM

0.00%

Seelos Therapeutics stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Seelos Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Seelos Therapeutics	NA	$5.0	NA	NA	203.13%	0.00%

Stock Returns calculator for Seelos Therapeutics Stock including INR - Dollar returns

The Seelos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Seelos Therapeutics investment value today

Current value as on today

Returns

(0%)

Returns from Seelos Therapeutics Stock

(0%)

Dollar Impact

(0%)

Indian Investors' Interest in Seelos Therapeutics Stock

Search interest for Seelos Therapeutics Stock has increased by 767% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 24, 2026 to October 24, 2026

Change:767% versus previous 30 day period

Seelos Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Income	-10	-12	-8	-6	-3
EBITDA	-	-	-	-	-
Interest Expense	0	0	0	0	0
Depreciation	0	0	0	0	0
Income Before Tax	-29	10	-5	-2	1
Income Tax Expense	-	-	-	-	-
Net Income	-29	10	-5	-2	1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Seelos Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	-18	-61	-70	-40
EBITDA	-	-64	-73	-37
Interest Expense	0	1	0	0
Depreciation	-	-	0	0
Income Before Tax	-19	-66	-73	-37
Income Tax Expense	-	-	-	-
Net Income	-19	-66	-73	-37
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Seelos Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Net Income	-29	10	-5	-2	1
Operating Cash Flow	-5	-5	-1	-4	0
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-2	2	2	2	0
Change in Cash	-8	-3	0	-2	0

Seelos Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023
Net Income	-66	-73	-37
Operating Cash Flow	-48	-61	-23
Investing Cash Flow	-	-	-
Financing Cash Flow	112	-1	11
Change in Cash	63	-63	-12

Global Institutional Holdings in Seelos Therapeutics

Check out the Institutions with significant holdings in Seelos Therapeutics.

Funds	Holdings
Victory Portfolios III	0.85%

About Seelos Therapeutics

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio include late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY.

Organisation	Seelos Therapeutics
Headquarters	300 Park Avenue,12th Floor, New York, NY, 10022, US
Industry	Biotechnology
CEO	Raj Mehra

Key Management of Seelos Therapeutics

Name	Title
Mr. Gopal Krishna Ph.D.	Head of Manufacturing & Technical Operations
Ms. Karen Fusaro	Senior VP & Head of Clinical Operations
Dr. Raj Mehra J.D., Ph.D.	CEO, Founder, President & Chairman
Mr. Michael J. Golembiewski	Chief Financial Officer
Mr. Anthony Marciano	Chief Communications Officer

FAQs

What is Seelos Therapeutics's market capitalisation today?

Seelos Therapeutics market capitalisation is $0.00T as on October 22, 2026 at 11:32 pm IST.

How to invest in Seelos Therapeutics Stock (SEELQ) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Seelos Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Seelos Therapeutics Stock (SEELQ) from India?

Indian investors can start investing in Seelos Therapeutics (SEELQ) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 1:12 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Seelos Therapeutics stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 1:12 am IST). Learn more about fractional shares .